{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:41:13Z","timestamp":1790401273983,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.pharep.2013.10.007","type":"journal-article","created":{"date-parts":[[2014,4,13]],"date-time":"2014-04-13T08:02:25Z","timestamp":1397376145000},"page":"394-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Role of glutamate and advantages of combining memantine with a 5HT6 ligand in a model of depression"],"prefix":"10.1007","volume":"66","author":[{"given":"Renny","family":"Abraham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramakrishna","family":"Nirogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Shinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2013.10.007_bib0105","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.pharmthera.2005.05.001","article-title":"5-HT6 receptors: a novel target for cognitive enhancement","volume":"108","author":"Mitchell","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharep.2013.10.007_bib0185","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1568007043482561","article-title":"5-ht6 receptors","volume":"3","author":"Woolley","year":"2004","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.1016\/j.pharep.2013.10.007_bib0020","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1124\/mol.54.3.577","article-title":"The 5-hydroxytryptamine 6 receptor-selective radioligand [3H] Ro 63-0563 labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum","volume":"54","author":"Boess","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharep.2013.10.007_bib0110","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0026-895X(25)13616-X","article-title":"Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs","volume":"43","author":"Monsma","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharep.2013.10.007_bib0150","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1097\/00001756-199412000-00037","article-title":"5-HT6 receptors positively coupled to adenylyl cyclase in striatal neurons in culture","volume":"5","author":"Sebben","year":"1994","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharep.2013.10.007_bib0070","first-page":"576","article-title":"Characterization of SB-399885, a potent and selective 5-HT6 receptor antagonist","volume":"29","author":"Hirst","year":"2003","journal-title":"Soc Neurosci Abstr"},{"key":"10.1016\/j.pharep.2013.10.007_bib0075","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejphar.2006.09.049","article-title":"SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models","volume":"553","author":"Hirst","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2013.10.007_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-385902-0.00001-2","article-title":"The central role of 5-HT6 receptors in modulating brain neurochemistry","volume":"96","author":"Dawson","year":"2011","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.pharep.2013.10.007_bib0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0306-4522(96)00435-6","article-title":"Temporal dynamics of glutamate efflux in the prefrontal cortex and in the hippocampus following repeated stress: effects of pretreatment with saline or diazepam","volume":"77","author":"Bagley","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharep.2013.10.007_bib0065","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1038\/tp.2012.9","article-title":"Forebrain glutamatergic neurons mediate leptin action on depression-like behaviors and synaptic depression","volume":"2","author":"Guo","year":"2012","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.pharep.2013.10.007_bib0100","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11920-007-0063-1","article-title":"The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects","volume":"9","author":"Maeng","year":"2007","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.pharep.2013.10.007_bib0145","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","article-title":"Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders","volume":"62","author":"Sanacora","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharep.2013.10.007_bib0195","doi-asserted-by":"crossref","first-page":"21773","DOI":"10.1074\/jbc.M112.363226","article-title":"Effects of N-acetylaspartylglutamate (NAAG) peptidase inhibition on release of glutamate and dopamine in prefrontal cortex","volume":"287","author":"Zuo","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharep.2013.10.007_bib0045","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0149-7634(96)00037-1","article-title":"Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents\u2014preclinical studies","volume":"21","author":"Danysz","year":"1997","journal-title":"Neurosci Biobehav Rev"},{"issue":"70","key":"10.1016\/j.pharep.2013.10.007_bib0035","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/2013.jamapsychiatry.24","article-title":"Evidence for increased glutamatergic cortical facilitation in children and adolescents with major depressive disorder","volume":"1","author":"Croarkin","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.pharep.2013.10.007_bib0015","first-page":"14","article-title":"A role for the serotonin system in the mechanism of action of antidepressants","volume":"51","author":"Blier","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharep.2013.10.007_bib0120","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0278-5846(97)00097-3","article-title":"Daily fluoxetine administration impairs avoidance learning in the rat without altering sensory thresholds","volume":"21","author":"Nelson","year":"1997","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharep.2013.10.007_bib0010","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0140-6736(11)60830-1","article-title":"Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial","volume":"378","author":"Banerjee","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.pharep.2013.10.007_bib0155","first-page":"217","article-title":"The synergistic effect of selective sigma receptor agonists and uncompetitive NMDA receptor antagonists in the forced swim test in rats","volume":"57","author":"Skuza","year":"2006","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.pharep.2013.10.007_bib0160","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/cercor\/bhp145","article-title":"A 1H-MR spectroscopy study of changes in glutamate and glutamine (Glx) concentrations in frontal spectra after administration of memantine","volume":"20","author":"van Wageningen","year":"2010","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.pharep.2013.10.007_bib0170","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejphar.2007.12.013","article-title":"The selective 5-HT6 receptor antagonist SB-399885 enhances anti-immobility action of antidepressants in rats","volume":"582","author":"Weso\u0142owska","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2013.10.007_bib0130","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","article-title":"Behavioural despair in rats: a new model sensitive to antidepressant treatments","volume":"47","author":"Porsolt","year":"1978","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2013.10.007_bib0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0378-4347(97)00677-4","article-title":"Determination of glutamate and aspartate in microdialysis samples by reversed-phase column liquid chromatography with fluorescence and electrochemical detection","volume":"708","author":"Kehr","year":"1998","journal-title":"J Chromatogr B: Biomed Sci Appl"},{"key":"10.1016\/j.pharep.2013.10.007_bib0125","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.2042-7158.1998.tb04010.x","article-title":"Nicotine-induced perturbations on heart rate, body temperature and locomotor property daily rhythms in rats","volume":"50","author":"Pelissier","year":"1998","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.pharep.2013.10.007_bib0165","series-title":"Drug discovery and evaluation (pharmacological assays)","first-page":"628","author":"Vogel","year":"2002"},{"key":"10.1016\/j.pharep.2013.10.007_bib0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0166-4328(88)90157-X","article-title":"A new one-trial test for neurobiological studies of memory in rats. 1. Behavioral data","volume":"31","author":"Ennaceur","year":"1988","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharep.2013.10.007_bib0140","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrd2462","article-title":"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders","volume":"7","author":"Sanacora","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharep.2013.10.007_bib0135","doi-asserted-by":"crossref","first-page":"385","DOI":"10.31887\/DCNS.2008.10.4\/gracagni","article-title":"Cellular and molecular mechanisms in the long-term action of antidepressants","volume":"10","author":"Racagni","year":"2008","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.pharep.2013.10.007_bib0060","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1176\/jnp.2010.22.3.256","article-title":"A hypothesized role for dendritic remodeling in the etiology of mood and anxiety disorders","volume":"22","author":"Gorman","year":"2010","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.pharep.2013.10.007_bib0175","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S1734-1140(10)70315-7","article-title":"Potential role of the 5-HT6 receptor in depression and anxiety: an overview of preclinical data","volume":"62","author":"Weso\u0142owska","year":"2010","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2013.10.007_bib0180","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/B978-0-12-385902-0.00003-6","article-title":"Behavioral pharmacology: potential antidepressant and anxiolytic properties","volume":"96","author":"Weso\u0142owska","year":"2010","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.pharep.2013.10.007_bib0090","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuropharm.2004.03.012","article-title":"5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation \u2013 an effect sensitive to NMDA receptor antagonism","volume":"47","author":"King","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharep.2013.10.007_bib0095","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0306-4522(02)00652-8","article-title":"Effects of ketamine and N-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268","volume":"117","author":"Lorrain","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharep.2013.10.007_bib0025","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2165\/00023210-200317090-00004","article-title":"The glutamatergic system and Alzheimer's disease: therapeutic implications","volume":"17","author":"Butterfield","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharep.2013.10.007_bib0115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4077\/CJP.2011.AMK077","article-title":"Effects of citalopram on cognitive performance in passive avoidance, elevated plus-maze and three-panel runway tasks in na\u00efve rats","volume":"54","author":"Mutlu","year":"2011","journal-title":"Chin J Physiol"},{"key":"10.1016\/j.pharep.2013.10.007_bib0050","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0166-4328(98)00079-5","article-title":"Extending the spontaneous preference test of recognition, evidence of object location and object context recognition","volume":"99","author":"Dix","year":"1999","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharep.2013.10.007_bib0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archpsyc.56.3.261","article-title":"The temporal relationship between depressive symptoms and dementia: a community based prospective study","volume":"56","author":"Chen","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharep.2013.10.007_bib0190","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archpsyc.56.5.425","article-title":"Depressive symptoms and cognitive decline in nondemented elderly women: a prospective study","volume":"56","author":"Yaffe","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharep.2013.10.007_bib0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0014-2999(02)01338-9","article-title":"Antidepressant property of memory-enhancing drugs in the reduction of submissive behavior model","volume":"440","author":"Knapp","year":"2002","journal-title":"Eur J Pharmacol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014001364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014001364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:35:18Z","timestamp":1752611718000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2013.10.007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1734114014001364"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2013.10.007","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of glutamate and advantages of combining memantine with a 5HT6 ligand in a model of depression","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2013.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Urban & Partner Sp. z o.o.","name":"copyright","label":"Copyright"}]}}